DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Current Value
$74.731 Year Return
Current Value
$74.731 Year Return
Market Cap
$29.25B
P/E Ratio
44.89
1Y Stock Return
-31.28%
1Y Revenue Growth
16.19%
Dividend Yield
0.00%
Price to Book
14.8
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BJRI | 38.46% | $780.10M | +11.11% | 0.00% |
SAIA | 36.26% | $13.72B | +22.08% | 0.00% |
WRLD | 35.66% | $667.35M | +5.26% | 0.00% |
SKYW | 29.47% | $4.43B | +136.32% | 0.00% |
MTX | 28.88% | $2.54B | +28.39% | 0.52% |
PEN | 28.76% | $9.10B | +2.99% | 0.00% |
BIIB | 27.34% | $22.65B | -32.30% | 0.00% |
SYK | 24.93% | $148.17B | +32.36% | 0.82% |
OLN | 24.46% | $4.77B | -12.57% | 1.96% |
BSX | 24.30% | $133.13B | +63.29% | 0.00% |
MSBI | 23.99% | $562.43M | +13.67% | 4.72% |
AMTB | 23.08% | $998.39M | +13.94% | 1.53% |
SXT | 23.02% | $3.24B | +33.26% | 2.15% |
PFG | 22.78% | $19.25B | +16.58% | 3.30% |
ABT | 22.77% | $203.16B | +14.93% | 1.88% |
ISRG | 22.34% | $191.92B | +72.80% | 0.00% |
VRTS | 22.22% | $1.63B | +19.88% | 3.42% |
RMD | 22.21% | $34.96B | +56.12% | 0.85% |
ABNB | 22.08% | $82.12B | +3.64% | 0.00% |
B | 21.73% | $2.38B | +80.47% | 1.37% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
WTTR | <0.01% | $1.45B | +92.87% | 1.78% |
GERN | <0.01% | $2.29B | +97.40% | 0.00% |
BKH | <0.01% | $4.49B | +23.18% | 4.16% |
KO | 0.01% | $269.63B | +7.86% | 3.07% |
AEG | -0.02% | $10.23B | +18.32% | 5.54% |
SEA | -0.02% | $1.36B | +27.44% | 0.00% |
HXL | -0.02% | $4.76B | -11.81% | 1.02% |
UDR | -0.02% | $14.68B | +35.67% | 3.83% |
DAVE | 0.02% | $1.04B | +1,258.83% | 0.00% |
JAZZ | 0.02% | $7.06B | -1.23% | 0.00% |
EQR | -0.02% | $28.27B | +32.70% | 3.63% |
CHGG | 0.02% | $175.24M | -83.42% | 0.00% |
CNH | -0.02% | $13.83B | +9.71% | 4.23% |
AVB | -0.02% | $32.63B | +34.34% | 2.94% |
FERG | 0.03% | $40.52B | +21.11% | 1.56% |
BANR | 0.04% | $2.49B | +62.84% | 2.67% |
UBSI | 0.04% | $5.66B | +25.92% | 3.55% |
DCI | 0.04% | $9.01B | +25.02% | 1.38% |
STC | 0.05% | $2.02B | +61.68% | 2.65% |
MWA | -0.05% | $3.80B | +86.48% | 1.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EVRI | -54.65% | $1.15B | +23.27% | 0.00% |
COUR | -51.40% | $1.08B | -64.26% | 0.00% |
MMM | -47.77% | $69.81B | +63.13% | 2.82% |
NWL | -42.04% | $3.67B | +20.00% | 3.04% |
IGT | -34.45% | $3.83B | -28.66% | 4.24% |
MHK | -29.59% | $8.56B | +61.48% | 0.00% |
CHTR | -27.27% | $54.72B | -4.38% | 0.00% |
BMY | -26.31% | $118.10B | +20.11% | 4.09% |
WF | -25.66% | $8.68B | +19.39% | 7.33% |
CABO | -22.54% | $2.24B | -27.54% | 2.99% |
NSC | -22.43% | $58.76B | +21.87% | 2.07% |
LBRDK | -22.03% | $12.37B | +4.89% | 0.00% |
LBRDA | -21.86% | $12.29B | +4.47% | 0.00% |
ERIE | -21.75% | $19.39B | +46.23% | 1.23% |
LFVN | -21.48% | $169.84M | +130.61% | 1.10% |
KNSL | -19.63% | $10.93B | +29.38% | 0.13% |
CLLS | -19.38% | $141.30M | -30.99% | 0.00% |
ATR | -19.23% | $11.11B | +30.48% | 1.03% |
AON | -19.22% | $82.00B | +16.33% | 0.70% |
HIG | -19.14% | $33.87B | +51.09% | 1.60% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHI | 40.59% | $4.91B | 0.4% |
XHE | 30.80% | $213.41M | 0.35% |
SNSR | 24.34% | $233.01M | 0.68% |
EDOC | 22.52% | $40.86M | 0.68% |
RSPH | 20.80% | $885.96M | 0.4% |
PFUT | 19.37% | $326.69M | 0.64% |
IWP | 18.18% | $17.19B | 0.23% |
BSJP | 16.95% | $1.00B | 0.42% |
ENZL | 16.71% | $84.50M | 0.5% |
VOT | 16.59% | $15.26B | 0.07% |
FHLC | 16.55% | $2.73B | 0.084% |
IYH | 16.31% | $3.19B | 0.39% |
GNOM | 16.10% | $70.59M | 0.5% |
PEJ | 16.06% | $257.98M | 0.57% |
XBI | 16.05% | $6.58B | 0.35% |
VHT | 15.98% | $17.06B | 0.1% |
IBB | 15.96% | $6.66B | 0.45% |
XSW | 15.89% | $402.79M | 0.35% |
FXH | 15.83% | $1.15B | 0.62% |
FXL | 15.65% | $1.39B | 0.62% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LTPZ | 0.04% | $715.65M | 0.2% |
CSHI | 0.05% | $482.85M | 0.38% |
SPTL | 0.05% | $10.33B | 0.03% |
VGLT | -0.07% | $12.70B | 0.04% |
SCHQ | -0.10% | $762.08M | 0.03% |
TLT | -0.12% | $57.46B | 0.15% |
DUSB | -0.14% | $797.63M | 0.15% |
ZROZ | -0.14% | $1.63B | 0.15% |
UTEN | 0.14% | $149.75M | 0.15% |
ILTB | -0.14% | $604.33M | 0.06% |
GCOR | -0.15% | $393.53M | 0.14% |
HTAB | -0.15% | $437.10M | 0.4% |
XLF | 0.21% | $50.48B | 0.09% |
GOVI | 0.24% | $1.06B | 0.15% |
MINT | -0.25% | $11.62B | 0.35% |
COWZ | -0.25% | $26.05B | 0.49% |
EPHE | 0.30% | $99.70M | 0.59% |
BNDW | 0.32% | $854.64M | 0.05% |
LDSF | 0.32% | $131.03M | 0.75% |
EUFN | 0.35% | $1.92B | 0.51% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BUXX | -15.29% | $162.67M | 0.25% |
HIGH | -14.40% | $302.78M | 0.51% |
ULST | -13.55% | $535.47M | 0.2% |
BOXX | -11.54% | $4.43B | 0.1949% |
BTAL | -10.81% | $388.04M | 1.43% |
RSPA | -10.64% | $273.87M | 0% |
USDU | -10.38% | $201.97M | 0.5% |
IBHD | -9.17% | $327.80M | 0.35% |
CTA | -8.74% | $350.27M | 0.78% |
VRP | -8.72% | $1.83B | 0.5% |
JPST | -8.47% | $28.43B | 0.18% |
EFAA | -8.42% | $117.38M | 0% |
PWZ | -8.38% | $697.36M | 0.28% |
FLTR | -8.01% | $1.79B | 0.14% |
UUP | -7.93% | $309.25M | 0.77% |
LQDW | -7.73% | $206.97M | 0.34% |
PULS | -7.47% | $8.78B | 0.15% |
TAIL | -7.46% | $67.98M | 0.59% |
FTSM | -7.11% | $6.08B | 0.45% |
TDTT | -6.84% | $1.84B | 0.18% |
Yahoo
If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor DexCom and Oura smart rings.
Yahoo
ŌURA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.
SeekingAlpha
Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.
Yahoo
SAN DIEGO & SAN FRANCISCO, November 19, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, and ŌURA, maker of the world’s leading smart ring, announced today a strategic partnership to help millions of people improve their metabolic health through the integration of Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from Oura Ring. Combining Dexcom glucose data with the biometrics collected by Oura Ring will provide users of both products w
Finnhub
Medical device maker Dexcom said on Tuesday it will invest $75 million in Oura's latest funding round, valuing the smart ring maker at over $5 billion. Oura, founded in Finland in 2013,...
MarketWatch
DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.